<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Vistalytics - iFile Suite version 6.233 -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2016-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://www.sigmalabs.com/20170331' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='sglb-20170331.xsd' />
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 1 &amp;#150; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Nature of Business &amp;#150; &lt;/b&gt;On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#147;reverse purchase&amp;#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#147;B6 Sigma&amp;#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#147;Company,&amp;#148; &amp;#147;Sigma,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;us&amp;#148; and &amp;#147;our&amp;#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&amp;#146;s Form 10-K. The results of operations for the periods ended March 31, 2017 and 2016 are not necessarily indicative of the operating results for the full year.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Loss Per Share &amp;#150; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#147;Earnings Per Share.&amp;#148;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#147;Codification&amp;#148; or &amp;#147;ASC&amp;#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#147;GAAP&amp;#148;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Recent Accounting Standards Updates (&amp;#147;ASU&amp;#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 2 &amp;#150; Stockholders&amp;#146; Equity&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Common Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &amp;#147;Certificate of Change&amp;#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &amp;#147;Reverse Stock Split&amp;#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#147;Share Decrease&amp;#148;). &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on March 17, 2016 decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statements are presented post-Reverse Stock Split. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;On April 28, 2016, the Company&amp;#146;s Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company&amp;#146;s common stock from 7,500,000 to 15,000,000 shares of common stock. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Effective February 15, 2017, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &amp;#147;Certificate of Change&amp;#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-2 basis (the &amp;#147;Reverse Stock Split&amp;#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#147;Share Decrease&amp;#148;). &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on February 15, 2017 decreased from 6,307,577 pre-Reverse Stock Split shares to 3,153,801 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 15,000,000 to 7,500,000 shares of common stock, $0.001 par value per share. As of March 31, 2017, the Company had 7,500,000 shares of authorized common stock, $0.001 par value per share. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;In January, 2017, the Company issued 20,000 shares of common stock to two directors in equal amounts of 10,000 shares each, valued at $1.72 per share, or $34,404. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;In February, 2017, the Company issued 5,232 shares of common stock to a director valued at $3.25 per share, or $17,004.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in -2.7pt 0pt 0in;text-indent:0in&apos;&gt;On February 14, 2017, The NASDAQ Stock Market LLC informed the Company that it had approved the listing of the Company&amp;#146;s common stock The NASDAQ Capital Market, effective as of February 15, 2017. The Company&amp;#146;s common stock ceased trading on the OTCQB on February 15, 2017, and on such date the common stock commenced trading on The NASDAQ Capital Market under the ticker symbol &amp;#147;SGLB&amp;#148;.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;As of March 31, 2017 and 2016, there were 4,570,199 and 3,133,789 shares of common stock issued and outstanding, respectively.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:;text-indent:0.5in&apos;&gt;&lt;b&gt;Preferred Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. No shares of preferred stock were issued and outstanding at March 31, 2017 and 2016.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0.5in&apos;&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0.5in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;During the quarter ended March 31, 2017, the Company granted a total of 123,750 options to an officer with an eighteen month vesting period. The weighted average period over which total the compensation cost of the options of $278,314 ($162,350 in 2017) will be recognized is 1.5 years. The weighted average exercise price of all outstanding options as of March 31, 2107 is $4.00 and the weighted average fair value of the options on the grant dates was $2.85. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions:&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Expected term:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;1.5 - 10 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Volatility:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;67.3 &amp;#150; 139.5%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Dividend yield:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Risk-free interest rate:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.79 - 2.32%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;As of March 31, 2017, the Company had outstanding warrants to purchase a total of 80,000 shares of common stock at an exercise price of $4.13 per share. If not exercised, the warrants to purchase the 80,000 shares will expire on October 17, 2019. In addition, as of March 31, 2017, the Company had outstanding warrants to purchase a total of 1,621,500 shares of common stock at an exercise price of $4.00 per share. If not exercised, the warrants to purchase the 1,621,500 shares will expire on February 21, 2022. The 1,621,500 warrants trade on The NASDAQ Capital Market under the ticker symbol &amp;#147;SGLBW&amp;#148;.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;Unit Purchase Option&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;On February 15, 2017, Sigma Labs, Inc. (the &amp;#147;Company&amp;#148;) entered into an underwriting agreement (the &amp;#147;Underwriting Agreement&amp;#148;) with Dawson James Securities, Inc., as underwriter (the &amp;#147;Underwriter&amp;#148;) in connection with a public offering (the &amp;#147;Offering&amp;#148;) of the Company&amp;#146;s securities. Pursuant to the Underwriting Agreement, the Company has granted the Underwriter the right to purchase from the Company 70,500 Units at an exercise price equal to 125% of the public offering price of the Units in the Offering, or $5.1625 per Unit. The Unit Purchase Option has a term of five years and is not redeemable by us. A &amp;#147;Unit&amp;#148; is defined as of one share of the Company&amp;#146;s common stock, par value $0.001 per share and one warrant to purchase one share of the Company&amp;#146;s common stock, par value $0.001 per share, at an exercise price of $4.00 per share. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 4&lt;/b&gt; &lt;b&gt;&amp;#150; Notes Payable&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;Effective October 17, 2016, the Company entered into a Securities Purchase Agreement with two accredited investors (the &amp;#147;Investors&amp;#148;) for the private placement by the Company of Secured Convertible Notes in the aggregate principal amount of $1,000,000 (the &amp;#147;Notes&amp;#148;) and warrants (the &amp;#147;Warrants&amp;#148;) to purchase up to 80,000 shares (the &amp;#147;Warrant Shares&amp;#148;) of the Company&amp;#146;s common stock (&amp;#147;Common Stock&amp;#148;) (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the &amp;#147;Financing Transaction&amp;#148;). &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0in&apos;&gt;The Notes carry a one-time upfront interest charge of a total of $100,000, which is being expensed to interest expense monthly over the 1-year term of the Notes and correspondingly increases in the Notes Payable balance each period. As of March 31, 2017, the Notes Payable balance is $944,772. However, the effective Notes Payable balance is $1 million since that is the amount we would have to pay in order to payoff the note anytime between now and the maturity date of October 17, 2017, in addition to accrued interest and a 15% pre-payment penalty. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-indent:0in&apos;&gt;The Notes carry an interest rate of 10% per annum, calculated on the basis of a 360-day year, based on the $1 million Notes Payable effective balance. Such interest is payable every three months in cash, or, at the holder&amp;#146;s option, in unrestricted shares of Common Stock, if a registration statement is then in effect for such shares of common stock.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;In connection with the Financing Transaction, the Company entered into a Registration Rights Agreement, dated October 17, 2016, with the Investors (the &amp;#147;Registration Rights Agreement&amp;#148;), pursuant to which the Company agreed to file a registration statement related to the Financing Transaction with the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) covering the resale of (i) the shares of Common Stock that will be issued to the Investors upon conversion of the Notes (the &amp;#147;Conversion Shares&amp;#148;), and (ii) the Warrant Shares that will be issued to the Investors upon exercise of the Warrants. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;The Notes are secured by the assets of the Company pursuant to a Security Agreement, dated October 17, 2016, between the Company and the &amp;#147;collateral agent&amp;#148; (as defined in the Notes) for the benefit of itself and each of the Investors.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;The Notes are convertible into shares of Common Stock at a conversion price equal to the lesser of (i) the final unit price of the Company&amp;#146;s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Notes (subject to adjustment as provided therein). As such, as of March 31, 2017, the conversion price of the Notes was $4.13, which is the final unit price of the Company&amp;#146;s public offering.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;Each Warrant has an exercise price equal to the lesser of (i) the final unit price of the Company&amp;#146;s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Warrants (subject to adjustment as provided therein), which Warrants may be exercised on a cashless basis as provided in the Warrants. As such, as of March 31, 2017, the exercise price of the Warrants was $4.13, which is the final unit price of the Company&amp;#146;s public offering.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
	<fil:ContinuingOperationsTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 5 - Continuing Operations&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in -2.7pt 0pt 0in;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in -2.7pt 0pt 0in;text-autospace:&apos;&gt;The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. On February 21, 2017, the Company closed an underwritten public offering of equity securities resulting in net proceeds of approximately $5.25 million, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. As such, the Company believes it has adequate working capital and cash to fund operations through 2017. &lt;/p&gt;</fil:ContinuingOperationsTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 6 &amp;#150; Loss Per Share&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;The following data show the amounts used in computing loss per share and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2017 and 2016:&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt -0.25in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;219&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:164.35pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Three Months Ending&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;March 31, 2017&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:windowtext 1pt solid;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:windowtext 1pt solid;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;March 31, 2016&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Loss from continuing&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Operations available to &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Common stockholders (numerator)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(943,965)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(470,667)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Weighted average number of &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;common shares Outstanding &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;used in loss per share during &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;the Period (denominator)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,835,875&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,116,865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 7&lt;/b&gt; &lt;b&gt;&amp;#150; Subsequent Events&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;On May 1, 2017, the Company completed funding a loan in the principal amount of $250,000 to Jaguar Precision Machine, LLC, a New Mexico limited liability company, pursuant to a Secured Convertible Promissory Note dated May 1, 2017 delivered by Jaguar to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on May 1, 2018, is secured by certain assets of Jaguar, and is convertible at the Company&amp;#146;s option into 10% of the outstanding shares of the common stock of Jaguar unless Jaguar exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Jaguar to, among other things, stand up a metallugical laboratory and become ASM9100 certified for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance. Sigma will receive from Jaguar priority for use of certain machines and services of Jaguar. &lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;On April 19, 2017, the Company granted a stock option to an officer to purchase up to of 20,000 shares of common stock, at an exercise price equal to $3.27 per share, which was the closing market price of our common stock on April 19, 2017 (i.e., the date of grant), which option is subject to vesting over a12 month vesting period.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:Cash decimals='INF' contextRef='E17Q1' unitRef='USD'>4633046</us-gaap:Cash>
	<us-gaap:Cash decimals='INF' contextRef='E16' unitRef='USD'>398391</us-gaap:Cash>
	<us-gaap:AccountsReceivableNet decimals='INF' contextRef='E17Q1' unitRef='USD'>157354</us-gaap:AccountsReceivableNet>
	<us-gaap:AccountsReceivableNet decimals='INF' contextRef='E16' unitRef='USD'>288236</us-gaap:AccountsReceivableNet>
	<us-gaap:NotesReceivableNet decimals='INF' contextRef='E17Q1' unitRef='USD'>500000</us-gaap:NotesReceivableNet>
	<us-gaap:NotesReceivableNet decimals='INF' contextRef='E16' unitRef='USD'>0</us-gaap:NotesReceivableNet>
	<us-gaap:InventoryNet decimals='INF' contextRef='E17Q1' unitRef='USD'>200973</us-gaap:InventoryNet>
	<us-gaap:InventoryNet decimals='INF' contextRef='E16' unitRef='USD'>187241</us-gaap:InventoryNet>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>29017</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E16' unitRef='USD'>36056</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>5520390</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E16' unitRef='USD'>909924</us-gaap:AssetsCurrent>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q1' unitRef='USD'>558310</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16' unitRef='USD'>564933</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='INF' contextRef='E17Q1' unitRef='USD'>237365</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='INF' contextRef='E16' unitRef='USD'>226450</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:RealEstateInvestmentsJointVentures decimals='INF' contextRef='E17Q1' unitRef='USD'>500</us-gaap:RealEstateInvestmentsJointVentures>
	<us-gaap:RealEstateInvestmentsJointVentures decimals='INF' contextRef='E16' unitRef='USD'>500</us-gaap:RealEstateInvestmentsJointVentures>
	<us-gaap:PrepaidExpenseNoncurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>165208</us-gaap:PrepaidExpenseNoncurrent>
	<us-gaap:PrepaidExpenseNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>167562</us-gaap:PrepaidExpenseNoncurrent>
	<us-gaap:OtherAssets decimals='INF' contextRef='E17Q1' unitRef='USD'>961383</us-gaap:OtherAssets>
	<us-gaap:OtherAssets decimals='INF' contextRef='E16' unitRef='USD'>959445</us-gaap:OtherAssets>
	<us-gaap:Assets decimals='INF' contextRef='E17Q1' unitRef='USD'>6481773</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E16' unitRef='USD'>1869369</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>280020</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16' unitRef='USD'>112175</us-gaap:AccountsPayableCurrent>
	<us-gaap:NotesPayable decimals='INF' contextRef='E17Q1' unitRef='USD'>944772</us-gaap:NotesPayable>
	<us-gaap:NotesPayable decimals='INF' contextRef='E16' unitRef='USD'>561834</us-gaap:NotesPayable>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>161781</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>125116</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E17Q1' unitRef='USD'>1386573</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>799125</us-gaap:LiabilitiesCurrent>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E17Q1' unitRef='USD'>0</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities decimals='INF' contextRef='E16' unitRef='USD'>93206</us-gaap:DerivativeLiabilities>
	<us-gaap:DeferredLongTermLiabilityCharges decimals='INF' contextRef='E17Q1' unitRef='USD'>0</us-gaap:DeferredLongTermLiabilityCharges>
	<us-gaap:DeferredLongTermLiabilityCharges decimals='INF' contextRef='E16' unitRef='USD'>93206</us-gaap:DeferredLongTermLiabilityCharges>
	<us-gaap:Liabilities decimals='INF' contextRef='E17Q1' unitRef='USD'>1386573</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E16' unitRef='USD'>892331</us-gaap:Liabilities>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E17Q1' unitRef='USD'>0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E16' unitRef='USD'>0</us-gaap:PreferredStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E17Q1' unitRef='USD'>4570</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E16' unitRef='USD'>3135</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E17Q1' unitRef='USD'>15795550</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16' unitRef='USD'>10734857</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E17Q1' unitRef='USD'>-10704919</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E16' unitRef='USD'>-9760954</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals='INF' contextRef='E17Q1' unitRef='USD'>5095201</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals='INF' contextRef='E16' unitRef='USD'>977038</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E17Q1' unitRef='USD'>6481773</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E16' unitRef='USD'>1869369</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LongTermDebtTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;NOTE 3 &amp;#150; Note Receivable&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;On March 27, 2017, the Company completed funding a loan in the principal amount of $500,000 to Morf3D, Inc., an Illinois corporation, pursuant to a Secured Convertible Promissory Note dated March 27, 2017 delivered by Morf3D to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on March 27, 2018, is secured by certain assets of Morf3D, and is convertible at the Company&amp;#146;s option into 10% of the outstanding shares of the common stock of Morf3D unless Morf3D exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Morf3D to, among other things, lease an EOS M 400 system for Morf3D for Morf3D to expand production for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance and in contemplation of a possible acquisition of or merger with Morf3D.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
	<us-gaap:ProfitLoss decimals='INF' contextRef='Y17Q1' unitRef='USD'>-943965</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='INF' contextRef='Y16Q1' unitRef='USD'>-470667</us-gaap:ProfitLoss>
	<us-gaap:AdjustmentForAmortization decimals='INF' contextRef='Y17Q1' unitRef='USD'>6526</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentForAmortization decimals='INF' contextRef='Y16Q1' unitRef='USD'>5002</us-gaap:AdjustmentForAmortization>
	<us-gaap:Depreciation decimals='INF' contextRef='Y17Q1' unitRef='USD'>39623</us-gaap:Depreciation>
	<us-gaap:Depreciation decimals='INF' contextRef='Y16Q1' unitRef='USD'>42868</us-gaap:Depreciation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y17Q1' unitRef='USD'>140671</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y16Q1' unitRef='USD'>71551</us-gaap:ShareBasedCompensation>
	<fil:RevaluationOfDerivativeLiabilityAndDebtDiscountRelatedToNotesPayable decimals='INF' contextRef='Y17Q1' unitRef='USD'>-93206</fil:RevaluationOfDerivativeLiabilityAndDebtDiscountRelatedToNotesPayable>
	<fil:RevaluationOfDerivativeLiabilityAndDebtDiscountRelatedToNotesPayable decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</fil:RevaluationOfDerivativeLiabilityAndDebtDiscountRelatedToNotesPayable>
	<fil:NotePayableOriginalIssueDiscount decimals='INF' contextRef='Y17Q1' unitRef='USD'>24658</fil:NotePayableOriginalIssueDiscount>
	<fil:NotePayableOriginalIssueDiscount decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</fil:NotePayableOriginalIssueDiscount>
	<us-gaap:IncreaseDecreaseInNotesPayableCurrent decimals='INF' contextRef='Y17Q1' unitRef='USD'>56441</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
	<us-gaap:IncreaseDecreaseInNotesPayableCurrent decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='Y17Q1' unitRef='USD'>130882</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='Y16Q1' unitRef='USD'>-101087</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='Y17Q1' unitRef='USD'>-13732</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='Y16Q1' unitRef='USD'>-74057</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInPrepaidExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>7039</us-gaap:IncreaseDecreaseInPrepaidExpense>
	<us-gaap:IncreaseDecreaseInPrepaidExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>16622</us-gaap:IncreaseDecreaseInPrepaidExpense>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='Y17Q1' unitRef='USD'>167845</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='INF' contextRef='Y16Q1' unitRef='USD'>105633</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInOtherAccruedLiabilities decimals='INF' contextRef='Y17Q1' unitRef='USD'>36665</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInOtherAccruedLiabilities decimals='INF' contextRef='Y16Q1' unitRef='USD'>11107</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='Y17Q1' unitRef='USD'>-440553</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='INF' contextRef='Y16Q1' unitRef='USD'>-393028</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:PaymentsToAcquireFurnitureAndFixtures decimals='INF' contextRef='Y17Q1' unitRef='USD'>-33000</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
	<us-gaap:PaymentsToAcquireFurnitureAndFixtures decimals='INF' contextRef='Y16Q1' unitRef='USD'>-25430</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='INF' contextRef='Y17Q1' unitRef='USD'>-17441</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='INF' contextRef='Y16Q1' unitRef='USD'>-34988</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:IncreaseDecreaseInNotesReceivables decimals='INF' contextRef='Y17Q1' unitRef='USD'>-500000</us-gaap:IncreaseDecreaseInNotesReceivables>
	<us-gaap:IncreaseDecreaseInNotesReceivables decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:IncreaseDecreaseInNotesReceivables>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='Y17Q1' unitRef='USD'>-550441</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='Y16Q1' unitRef='USD'>-60418</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF' contextRef='Y17Q1' unitRef='USD'>5225649</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='Y17Q1' unitRef='USD'>5225649</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='Y17Q1' unitRef='USD'>4234655</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='INF' contextRef='Y16Q1' unitRef='USD'>-453446</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E16' unitRef='USD'>398391</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E15' unitRef='USD'>1539809</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E17Q1' unitRef='USD'>4633046</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E16Q1' unitRef='USD'>1086363</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:InterestPaid decimals='INF' contextRef='Y17Q1' unitRef='USD'>20114</us-gaap:InterestPaid>
	<us-gaap:InterestPaid decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:InterestPaid>
	<us-gaap:IncomeTaxesPaidNet decimals='INF' contextRef='Y17Q1' unitRef='USD'>0</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncomeTaxesPaidNet decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='INF' contextRef='Y17Q1' unitRef='USD'>51408</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
	<us-gaap:Revenues decimals='INF' contextRef='Y17Q1' unitRef='USD'>150203</us-gaap:Revenues>
	<us-gaap:Revenues decimals='INF' contextRef='Y16Q1' unitRef='USD'>358455</us-gaap:Revenues>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y17Q1' unitRef='USD'>74534</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y16Q1' unitRef='USD'>107581</us-gaap:CostOfRevenue>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y17Q1' unitRef='USD'>75669</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y16Q1' unitRef='USD'>250874</us-gaap:GrossProfit>
	<us-gaap:OtherGeneralAndAdministrativeExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>643795</us-gaap:OtherGeneralAndAdministrativeExpense>
	<us-gaap:OtherGeneralAndAdministrativeExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>395488</us-gaap:OtherGeneralAndAdministrativeExpense>
	<fil:PayrollExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>376621</fil:PayrollExpense>
	<fil:PayrollExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>215589</fil:PayrollExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>139632</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>71551</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>48762</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>39071</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y17Q1' unitRef='USD'>1208810</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y16Q1' unitRef='USD'>721699</us-gaap:OperatingExpenses>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='Y17Q1' unitRef='USD'>343</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='Y16Q1' unitRef='USD'>158</us-gaap:InvestmentIncomeInterest>
	<us-gaap:OtherIncome decimals='INF' contextRef='Y17Q1' unitRef='USD'>152068</us-gaap:OtherIncome>
	<us-gaap:OtherIncome decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:OtherIncome>
	<us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease decimals='INF' contextRef='Y17Q1' unitRef='USD'>93206</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
	<us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
	<us-gaap:OtherExpenses decimals='INF' contextRef='Y17Q1' unitRef='USD'>-56441</us-gaap:OtherExpenses>
	<us-gaap:OtherExpenses decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</us-gaap:OtherExpenses>
	<us-gaap:OtherNonoperatingIncomeExpense decimals='INF' contextRef='Y17Q1' unitRef='USD'>189176</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense decimals='INF' contextRef='Y16Q1' unitRef='USD'>158</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y17Q1' unitRef='USD'>-943965</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y16Q1' unitRef='USD'>-470667</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<fil:ProvisionForIncomeTaxes1 decimals='INF' contextRef='Y17Q1' unitRef='USD'>0</fil:ProvisionForIncomeTaxes1>
	<fil:ProvisionForIncomeTaxes1 decimals='INF' contextRef='Y16Q1' unitRef='USD'>0</fil:ProvisionForIncomeTaxes1>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y17Q1' unitRef='USD'>-943965</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y16Q1' unitRef='USD'>-470667</us-gaap:NetIncomeLoss>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y17Q1' unitRef='UsdPerShare'>-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y16Q1' unitRef='UsdPerShare'>-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y17Q1' unitRef='Shares'>3835875</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y16Q1' unitRef='Shares'>3116865</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;The following data show the amounts used in computing loss per share and the weighted average number of shares of dilutive potential common stock for the periods ended March 31, 2017 and 2016:&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt -0.25in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;219&quot; colspan=&quot;3&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:164.35pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;Three Months Ending&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;March 31, 2017&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:windowtext 1pt solid;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:windowtext 1pt solid;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;March 31, 2016&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Loss from continuing&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Operations available to &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;top&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Common stockholders (numerator)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(943,965)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;$&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;(470,667)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Weighted average number of &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;common shares Outstanding &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;used in loss per share during &lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style=&apos;height:0.1in&apos;&gt; &lt;td valign=&quot;top&quot; width=&quot;221&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:2.3in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;the Period (denominator)&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;101&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:75.5pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,835,875&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;16&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:11.8pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;103&quot; style=&apos;border-top:#f0f0f0;height:0.1in;border-right:#f0f0f0;width:77.05pt;border-bottom:windowtext 1.5pt double;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;text-align:right;margin:0in 0in 0pt&apos;&gt;3,116,865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions:&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; border=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Expected term:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;1.5 - 10 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Volatility:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;67.3 &amp;#150; 139.5%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Dividend yield:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign=&quot;top&quot; width=&quot;181&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:135.45pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Risk-free interest rate:&lt;/p&gt;&lt;/td&gt; &lt;td valign=&quot;bottom&quot; width=&quot;97&quot; style=&apos;border-top:#f0f0f0;border-right:#f0f0f0;width:72.9pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:5.4pt;border-left:#f0f0f0;padding-right:5.4pt;background-color:transparent&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;text-align:center;margin:0in 0in 0pt&apos;&gt;.79 - 2.32%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
	<fil:NatureOfBusinessPolicyTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Nature of Business &amp;#150; &lt;/b&gt;On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#147;reverse purchase&amp;#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#147;B6 Sigma&amp;#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#147;Company,&amp;#148; &amp;#147;Sigma,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;us&amp;#148; and &amp;#147;our&amp;#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt;text-autospace:&apos;&gt;B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.&lt;/p&gt;</fil:NatureOfBusinessPolicyTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at March 31, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&amp;#146;s Form 10-K. The results of operations for the periods ended March 31, 2017 and 2016 are not necessarily indicative of the operating results for the full year.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Loss Per Share &amp;#150; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#147;Earnings Per Share.&amp;#148;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#147;Codification&amp;#148; or &amp;#147;ASC&amp;#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#147;GAAP&amp;#148;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;Recent Accounting Standards Updates (&amp;#147;ASU&amp;#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:UseOfEstimates contextRef='Y17Q1'>&lt;!--egx--&gt;&lt;p style=&apos;text-align:justify;margin:0in 0in 0pt&apos;&gt;&lt;b&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<fil:NetOfOriginalIssueDiscountNotesPayable decimals='INF' contextRef='E17Q1' unitRef='USD'>55228</fil:NetOfOriginalIssueDiscountNotesPayable>
	<fil:NetOfOriginalIssueDiscountNotesPayable decimals='INF' contextRef='E16' unitRef='USD'>55228</fil:NetOfOriginalIssueDiscountNotesPayable>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E17Q1' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E16' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued decimals='INF' contextRef='E17Q1' unitRef='Shares'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued decimals='INF' contextRef='E16' unitRef='Shares'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E17Q1' unitRef='Shares'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E16' unitRef='Shares'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E17Q1' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E17Q1' unitRef='Shares'>4570199</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16' unitRef='Shares'>3133789</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E17Q1' unitRef='Shares'>4570199</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16' unitRef='Shares'>3133789</us-gaap:CommonStockSharesOutstanding>
	<fil:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions1 decimals='INF' contextRef='I100913' unitRef='Pure'>1.0000</fil:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions1>
	<fil:NumberOfSharesExchangedForEachShareOfAcquiredEntity decimals='INF' contextRef='I100913' unitRef='UsdPerShare'>6.67</fil:NumberOfSharesExchangedForEachShareOfAcquiredEntity>
	<fil:NumberOfIssuedAndOutstandingSharesOfOurCommonStockDecreased decimals='INF' contextRef='I160317' unitRef='Shares'>622969835</fil:NumberOfIssuedAndOutstandingSharesOfOurCommonStockDecreased>
	<fil:ReverseStockSplitShares decimals='INF' contextRef='I160317' unitRef='Shares'>6229710</fil:ReverseStockSplitShares>
	<fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedFrom750000000To decimals='INF' contextRef='I160317' unitRef='Shares'>7500000</fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedFrom750000000To>
	<fil:IncreaseTheNumberOfAuthorizedSharesOfTheCommonStockFrom7500000To decimals='INF' contextRef='I160428' unitRef='Shares'>15000000</fil:IncreaseTheNumberOfAuthorizedSharesOfTheCommonStockFrom7500000To>
	<fil:NumberOfIssuedAndOutstandingSharesOfOurCommonStockDecreased1 decimals='INF' contextRef='I170215' unitRef='Shares'>6307577</fil:NumberOfIssuedAndOutstandingSharesOfOurCommonStockDecreased1>
	<fil:PreReverseStockSplitShares decimals='INF' contextRef='I170215' unitRef='Shares'>3153801</fil:PreReverseStockSplitShares>
	<fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedFrom15000000To decimals='INF' contextRef='I170215' unitRef='Shares'>7500000</fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedFrom15000000To>
	<fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedParValuePerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>0.001</fil:NumberOfAuthorizedSharesOfOurCommonStockDecreasedParValuePerShare>
	<fil:CompanyHadSharesOfAuthorizedCommonStock decimals='INF' contextRef='I170215' unitRef='Shares'>7500000</fil:CompanyHadSharesOfAuthorizedCommonStock>
	<fil:CompanyHadSharesOfAuthorizedCommonStockParValuePerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>0.001</fil:CompanyHadSharesOfAuthorizedCommonStockParValuePerShare>
	<fil:CompanyIssuedSharesOfCommonStockToTwoDirectors decimals='INF' contextRef='I170131' unitRef='Shares'>20000</fil:CompanyIssuedSharesOfCommonStockToTwoDirectors>
	<fil:CompanyIssuedSharesOfCommonStockToTwoDirectorsValuedAtPerShare decimals='INF' contextRef='I170131' unitRef='UsdPerShare'>1.72</fil:CompanyIssuedSharesOfCommonStockToTwoDirectorsValuedAtPerShare>
	<fil:CompanyIssuedSharesOfCommonStockToTwoDirectorsAmounts decimals='INF' contextRef='I170131' unitRef='USD'>34404</fil:CompanyIssuedSharesOfCommonStockToTwoDirectorsAmounts>
	<fil:CompanyIssuedSharesOfCommonStockToADirector decimals='INF' contextRef='I170228' unitRef='Shares'>5232</fil:CompanyIssuedSharesOfCommonStockToADirector>
	<fil:CompanyIssuedSharesOfCommonStockToADirectorValuedAt decimals='INF' contextRef='I170228' unitRef='USD'>17004</fil:CompanyIssuedSharesOfCommonStockToADirectorValuedAt>
	<fil:CompanyIssuedSharesOfCommonStockToADirectorValuedAtPerShare decimals='INF' contextRef='I170228' unitRef='UsdPerShare'>3.25</fil:CompanyIssuedSharesOfCommonStockToADirectorValuedAtPerShare>
	<fil:SharesOfCommonStockIssuedAndOutstanding decimals='INF' contextRef='E17Q1' unitRef='Shares'>4570199</fil:SharesOfCommonStockIssuedAndOutstanding>
	<fil:SharesOfCommonStockIssuedAndOutstanding decimals='INF' contextRef='E16Q1' unitRef='Shares'>3133789</fil:SharesOfCommonStockIssuedAndOutstanding>
	<fil:CompanyIsAuthorizedToIssueSharesOfPreferredStock decimals='INF' contextRef='E17Q1' unitRef='Shares'>10000000</fil:CompanyIsAuthorizedToIssueSharesOfPreferredStock>
	<fil:CompanyIsAuthorizedToIssueSharesOfPreferredStock decimals='INF' contextRef='E16Q1' unitRef='Shares'>10000000</fil:CompanyIsAuthorizedToIssueSharesOfPreferredStock>
	<fil:CompanyIsAuthorizedToIssueSharesOfPreferredStockParValuePerShare decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>0.001</fil:CompanyIsAuthorizedToIssueSharesOfPreferredStockParValuePerShare>
	<fil:CompanyIsAuthorizedToIssueSharesOfPreferredStockParValuePerShare decimals='INF' contextRef='E16Q1' unitRef='UsdPerShare'>0.001</fil:CompanyIsAuthorizedToIssueSharesOfPreferredStockParValuePerShare>
	<fil:CompanyGrantedATotalOfOptions decimals='INF' contextRef='E17Q1' unitRef='Shares'>123750</fil:CompanyGrantedATotalOfOptions>
	<fil:TotalCompensationCostOfTheOptions decimals='INF' contextRef='E17Q1' unitRef='USD'>162350</fil:TotalCompensationCostOfTheOptions>
	<fil:TotalCompensationCostOfTheOptions decimals='INF' contextRef='E16' unitRef='USD'>278314</fil:TotalCompensationCostOfTheOptions>
	<fil:TotalCompensationCostOfTheOptionsWillBeRecognizedInYears decimals='INF' contextRef='E17Q1' unitRef='Pure'>1.50</fil:TotalCompensationCostOfTheOptionsWillBeRecognizedInYears>
	<fil:WeightedAverageExercisePriceOfTheOptions decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>4.00</fil:WeightedAverageExercisePriceOfTheOptions>
	<fil:WeightedAverageFairValueOfTheOptionsOnTheDatesOfGrant decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>2.85</fil:WeightedAverageFairValueOfTheOptionsOnTheDatesOfGrant>
	<fil:ExpectedTermInYearsMinimum decimals='INF' contextRef='E17Q1' unitRef='Pure'>1.5</fil:ExpectedTermInYearsMinimum>
	<fil:ExpectedTermInYearsMinimum decimals='INF' contextRef='E16' unitRef='Pure'>1.5</fil:ExpectedTermInYearsMinimum>
	<fil:ExpectedTermInYearsMaximum decimals='INF' contextRef='E17Q1' unitRef='Pure'>10</fil:ExpectedTermInYearsMaximum>
	<fil:ExpectedTermInYearsMaximum decimals='INF' contextRef='E16' unitRef='Pure'>10</fil:ExpectedTermInYearsMaximum>
	<fil:VolatilityMinimum decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.6730</fil:VolatilityMinimum>
	<fil:VolatilityMinimum decimals='INF' contextRef='E16' unitRef='Pure'>0.6730</fil:VolatilityMinimum>
	<fil:VolatilityMaximum decimals='INF' contextRef='E17Q1' unitRef='Pure'>1.3950</fil:VolatilityMaximum>
	<fil:VolatilityMaximum decimals='INF' contextRef='E16' unitRef='Pure'>1.3950</fil:VolatilityMaximum>
	<fil:DividendYield1 decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.0000</fil:DividendYield1>
	<fil:DividendYield1 decimals='INF' contextRef='E16' unitRef='Pure'>0.0000</fil:DividendYield1>
	<fil:RiskFreeInterestRateMinimum decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.0079</fil:RiskFreeInterestRateMinimum>
	<fil:RiskFreeInterestRateMinimum decimals='INF' contextRef='E16' unitRef='Pure'>0.0079</fil:RiskFreeInterestRateMinimum>
	<fil:RiskFreeInterestRateMaximum decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.0232</fil:RiskFreeInterestRateMaximum>
	<fil:RiskFreeInterestRateMaximum decimals='INF' contextRef='E16' unitRef='Pure'>0.0232</fil:RiskFreeInterestRateMaximum>
	<fil:WarrantToPurchaseSharesOfCommonStock4 decimals='INF' contextRef='E17Q1' unitRef='Shares'>80000</fil:WarrantToPurchaseSharesOfCommonStock4>
	<fil:WarrantToPurchaseSharesOfCommonStockAtAnExercisePricePerShare3 decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>4.13</fil:WarrantToPurchaseSharesOfCommonStockAtAnExercisePricePerShare3>
	<fil:WarrantToPurchaseSharesOfCommonStock5 decimals='INF' contextRef='E17Q1' unitRef='Shares'>1621500</fil:WarrantToPurchaseSharesOfCommonStock5>
	<fil:WarrantToPurchaseSharesOfCommonStockAtAnExercisePricePerShare4 decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>4.00</fil:WarrantToPurchaseSharesOfCommonStockAtAnExercisePricePerShare4>
	<fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnits decimals='INF' contextRef='I170215' unitRef='Pure'>70500</fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnits>
	<fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnitsAtAnExercisePriceEqualTo decimals='INF' contextRef='I170215' unitRef='Pure'>1.2500</fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnitsAtAnExercisePriceEqualTo>
	<fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnitsPerUnit decimals='INF' contextRef='I170215' unitRef='Pure'>5.1625</fil:CompanyHasGrantedTheUnderwriterTheRightToPurchaseFromTheCompanyUnitsPerUnit>
	<fil:AUnitIsDefinedAsOfOneShareOfTheCompanySCommonStockParValuePerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>0.001</fil:AUnitIsDefinedAsOfOneShareOfTheCompanySCommonStockParValuePerShare>
	<fil:OneWarrantToPurchaseOneShareOfTheCompanySCommonStockParValuePerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>0.001</fil:OneWarrantToPurchaseOneShareOfTheCompanySCommonStockParValuePerShare>
	<fil:OneWarrantToPurchaseOneShareOfTheCompanySCommonStockAtAnExercisePriceOfPerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>4.00</fil:OneWarrantToPurchaseOneShareOfTheCompanySCommonStockAtAnExercisePriceOfPerShare>
	<fil:CompanyCompletedFundingALoanInThePrincipalAmount decimals='INF' contextRef='I170327' unitRef='USD'>500000</fil:CompanyCompletedFundingALoanInThePrincipalAmount>
	<fil:LoanBearsInterestAtTheRateOfPerAnnum decimals='INF' contextRef='I170327' unitRef='Pure'>0.0700</fil:LoanBearsInterestAtTheRateOfPerAnnum>
	<fil:SecuredConvertibleNotesInTheAggregatePrincipalAmount decimals='INF' contextRef='I161017' unitRef='USD'>1000000</fil:SecuredConvertibleNotesInTheAggregatePrincipalAmount>
	<fil:WarrantsToPurchaseSharesOfTheCompanySCommonStock decimals='INF' contextRef='I161017' unitRef='Shares'>80000</fil:WarrantsToPurchaseSharesOfTheCompanySCommonStock>
	<fil:AggregateGrossProceedsBeforeExpensesToTheCompany decimals='INF' contextRef='I161017' unitRef='USD'>900000</fil:AggregateGrossProceedsBeforeExpensesToTheCompany>
	<fil:NotesCarryAOneTimeUpfrontInterestCharge decimals='INF' contextRef='I161017' unitRef='USD'>100000</fil:NotesCarryAOneTimeUpfrontInterestCharge>
	<fil:NotesPayableBalance decimals='INF' contextRef='E17Q1' unitRef='USD'>944772</fil:NotesPayableBalance>
	<fil:NotesCarryAnInterestRatePerAnnum decimals='INF' contextRef='E17Q1' unitRef='Pure'>0.1000</fil:NotesCarryAnInterestRatePerAnnum>
	<fil:ConversionPriceOfTheNotes decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>4.13</fil:ConversionPriceOfTheNotes>
	<fil:ConversionPriceOfTheNotesOfTheClosingPriceOfTheCommonStock decimals='INF' contextRef='E17Q1' unitRef='Pure'>1.5000</fil:ConversionPriceOfTheNotesOfTheClosingPriceOfTheCommonStock>
	<fil:ExercisePriceOfTheWarrants decimals='INF' contextRef='E17Q1' unitRef='UsdPerShare'>4.13</fil:ExercisePriceOfTheWarrants>
	<fil:CompanyClosedAnUnderwrittenPublicOfferingOfEquitySecuritiesResultingInNetProceeds decimals='INF' contextRef='I170221' unitRef='USD'>52500000</fil:CompanyClosedAnUnderwrittenPublicOfferingOfEquitySecuritiesResultingInNetProceeds>
	<fil:LossFromContinuingOperationsAvailableToCommonStockholdersNumerator decimals='INF' contextRef='Y17Q1' unitRef='USD'>-943965</fil:LossFromContinuingOperationsAvailableToCommonStockholdersNumerator>
	<fil:LossFromContinuingOperationsAvailableToCommonStockholdersNumerator decimals='INF' contextRef='Y16Q1' unitRef='USD'>-470667</fil:LossFromContinuingOperationsAvailableToCommonStockholdersNumerator>
	<fil:WeightedAverageNumberOfCommonSharesOutstandingUsedInLossPerShareDuringThePeriodDenominator decimals='INF' contextRef='Y17Q1' unitRef='Shares'>3835875</fil:WeightedAverageNumberOfCommonSharesOutstandingUsedInLossPerShareDuringThePeriodDenominator>
	<fil:WeightedAverageNumberOfCommonSharesOutstandingUsedInLossPerShareDuringThePeriodDenominator decimals='INF' contextRef='Y16Q1' unitRef='Shares'>3116865</fil:WeightedAverageNumberOfCommonSharesOutstandingUsedInLossPerShareDuringThePeriodDenominator>
	<fil:CompanyCompletedFundingALoanInThePrincipalAmount1 decimals='INF' contextRef='I170501' unitRef='USD'>250000</fil:CompanyCompletedFundingALoanInThePrincipalAmount1>
	<fil:CompanyGrantedAStockOptionToAnOfficerToPurchaseSharesOfCommonStock decimals='INF' contextRef='I170419' unitRef='Shares'>20000</fil:CompanyGrantedAStockOptionToAnOfficerToPurchaseSharesOfCommonStock>
	<fil:CompanyGrantedAStockOptionToAnOfficerToPurchaseSharesOfCommonStockAtAnExercisePricePerShare decimals='INF' contextRef='I170419' unitRef='UsdPerShare'>3.27</fil:CompanyGrantedAStockOptionToAnOfficerToPurchaseSharesOfCommonStockAtAnExercisePricePerShare>
	<dei:DocumentType contextRef='Y17Q1'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='Y17Q1'>2017-03-31</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='Y17Q1'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='Y17Q1'>SIGMA LABS, INC.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='Y17Q1'>0000788611</dei:EntityCentralIndexKey>
	<dei:TradingSymbol contextRef='Y17Q1'>sglb</dei:TradingSymbol>
	<dei:CurrentFiscalYearEndDate contextRef='Y17Q1'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='I170515' unitRef='Shares'>4570199</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef='Y17Q1'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='Y17Q1'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='Y17Q1'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='Y17Q1'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='Y17Q1'>2017</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='Y17Q1'>Q1</dei:DocumentFiscalPeriodFocus>
	<context id='Y17Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-03-31</endDate>
		</period>
	</context>
	<context id='I170515'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-05-15</instant>
		</period>
	</context>
	<context id='E17Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-03-31</instant>
		</period>
	</context>
	<context id='E16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='Y16Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-03-31</endDate>
		</period>
	</context>
	<context id='E15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E16Q1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-03-31</instant>
		</period>
	</context>
	<context id='I100913'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2010-09-13</instant>
		</period>
	</context>
	<context id='I160317'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-03-17</instant>
		</period>
	</context>
	<context id='I160428'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-04-28</instant>
		</period>
	</context>
	<context id='I170215'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-02-15</instant>
		</period>
	</context>
	<context id='I170131'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-01-31</instant>
		</period>
	</context>
	<context id='I170228'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-02-28</instant>
		</period>
	</context>
	<context id='I170327'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-03-27</instant>
		</period>
	</context>
	<context id='I161017'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-10-17</instant>
		</period>
	</context>
	<context id='I170221'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-02-21</instant>
		</period>
	</context>
	<context id='I170501'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-05-01</instant>
		</period>
	</context>
	<context id='I170419'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-04-19</instant>
		</period>
	</context>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
</xbrl>
